Publications by authors named "RuQuan You"

Claim this Profile
I
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies.
Mark Lebwohl, Lars Iversen, Liv Eidsmo, James G Krueger, Mayte Suárez-Fariñas, Ruquan You

Clin Exp Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
Richard G Langley, Howard Sofen, Ignacio Dei-Cas, Kristian Reich, Bardur Sigurgeirsson, Ruquan You

Br J Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugate heat transfer study of various cooling structures and sensitivity analysis of overall cooling effectiveness.
Runzhou Liu, Haiwang Li, Ruquan You, Yi Huang, Zhi Tao

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial.
Matthias Augustin, Kristian Reich, Paul Yamauchi, Andreas Pinter, Jerry Bagel, Ruquan You

Br J Dermatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Pediatric Development for Secukinumab in Psoriasis: Faster Patient Access, Reduction of Patients on Control.
Ruquan You, Sebastian Weber, Bruno Bieth, Marc Vandemeulebroecke

Clin Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Investigation on Velocity and Temperature Field in a Rotating Non-isothermal Turbulent Boundary Layer using Hot-wire.
Li Gangfu, Li Haiwang, You Ruquan, Wu Huijie, Tao Zhi

Sci Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Stephen Tyring, Francisco Vanaclocha, Ruquan You

J Am Acad Dermatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
Alice Gottlieb, John Sullivan, Martijn van Doorn, Alexey Kubanov, Ruquan You

J Am Acad Dermatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Ruquan You

J Am Acad Dermatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Area level deprivation and drinking patterns among adolescents.
Mathilde Vinther-Larsen, Taisia Huckle, RuQuan You, Sally Casswell

Health Place· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis